Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Larimar Therapeutics Quick Ratio 2012-2024 | LRMR

Historical quick ratio values for Larimar Therapeutics (LRMR) over the last 10 years.
  
Larimar Therapeutics Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2024-03-31 $0.00B $0.01B 0.00
2023-12-31 $0.00B $0.01B 0.00
2023-09-30 $0.00B $0.01B 0.00
2023-06-30 $0.00B $0.01B 0.00
2023-03-31 $0.00B $0.01B 0.00
2022-12-31 $0.00B $0.01B 0.00
2022-09-30 $0.00B $0.01B 0.00
2022-06-30 $0.00B $0.01B 0.00
2022-03-31 $0.00B $0.01B 0.00
2021-12-31 $0.00B $0.01B 0.00
2021-09-30 $0.00B $0.01B 0.00
2021-06-30 $0.00B $0.01B 0.00
2021-03-31 $0.00B $0.01B 0.00
2020-12-31 $0.00B $0.01B 0.00
2020-09-30 $0.00B $0.01B 0.00
2020-06-30 $0.00B $0.01B 0.00
2020-03-31 $0.00B $0.01B 0.00
2019-12-31 $0.00B $0.01B 0.00
2019-09-30 $0.00B $0.02B 0.00
2019-06-30 $0.00B $0.01B 0.00
2019-03-31 $0.00B $0.01B 0.00
2018-12-31 $0.00B $0.01B 0.00
2018-09-30 $0.00B $0.01B 0.00
2018-06-30 $0.00B $0.01B 0.00
2018-03-31 $0.00B $0.01B 0.00
2017-12-31 $0.00B $0.01B 0.00
2017-09-30 $0.00B $0.01B 0.00
2017-06-30 $0.00B $0.01B 0.00
2017-03-31 $0.00B $0.01B 0.00
2016-12-31 $0.00B $0.01B 0.00
2016-09-30 $0.00B $0.01B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.01B 0.00
2015-12-31 $0.00B $0.02B 0.00
2015-09-30 $0.00B $0.01B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.01B 0.00
2014-12-31 $0.00B $0.01B 0.00
2014-09-30 $0.00B $0.01B 0.00
2014-06-30 $0.00B $0.00B 0.00
2014-03-31 $0.00B $0.00B 0.00
2013-12-31 $0.00B $0.00B 0.00
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.463B $0.000B
Larimar Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing treatments for rare diseases. The company's lead product consist CTI-1601, which is in clinical stage. Larimar Therapeutics Inc., formerly known as Zafgen Inc., is based in BALA CYNWYD, Pa.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.103B 32.16
Chugai Pharmaceutical (CHGCY) Japan $58.463B 26.13
Takeda Pharmaceutical (TAK) Japan $40.953B 8.29
Merck (MKGAF) Germany $21.654B 21.00
Astellas Pharma (ALPMY) Japan $17.843B 28.17
Sandoz Group AG (SDZNY) Switzerland $15.602B 0.00
United Therapeutics (UTHR) United States $14.130B 15.06
Neurocrine Biosciences (NBIX) United States $13.855B 37.93
Shionogi (SGIOY) Japan $11.518B 10.01
Catalent (CTLT) United States $10.177B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.450B 0.00
Ionis Pharmaceuticals (IONS) United States $6.957B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.731B 7.40
Revolution Medicines (RVMD) United States $6.403B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.971B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $5.475B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.532B 0.00
Corcept Therapeutics (CORT) United States $3.383B 30.65
Arrowhead Pharmaceuticals (ARWR) United States $3.228B 0.00
Dyne Therapeutics (DYN) United States $3.084B 0.00
PTC Therapeutics (PTCT) United States $2.345B 0.00
Indivior (INDV) United States $2.223B 10.54
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.960B 11.14
Catalyst Pharmaceuticals (CPRX) United States $1.830B 17.81
Recursion Pharmaceuticals (RXRX) United States $1.782B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.728B 0.00
Ardelyx (ARDX) United States $1.724B 0.00
Evotec AG (EVO) Germany $1.701B 0.00
Soleno Therapeutics (SLNO) United States $1.363B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.351B 0.00
Pacira BioSciences (PCRX) United States $1.332B 12.66
BioCryst Pharmaceuticals (BCRX) United States $1.275B 0.00
Xencor (XNCR) United States $1.167B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.162B 0.00
Enliven Therapeutics (ELVN) United States $1.099B 0.00
4D Molecular Therapeutics (FDMT) United States $1.085B 0.00
Ocular Therapeutix (OCUL) United States $1.059B 0.00
Collegium Pharmaceutical (COLL) United States $1.053B 6.30
Ironwood Pharmaceuticals (IRWD) United States $1.021B 15.90
Centessa Pharmaceuticals (CNTA) United Kingdom $0.907B 0.00
Cronos Group (CRON) Canada $0.891B 0.00
Relay Therapeutics (RLAY) United States $0.865B 0.00
USANA Health Sciences (USNA) United States $0.862B 14.09
ARS Pharmaceuticals (SPRY) United States $0.825B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.815B 0.00
Harrow (HROW) United States $0.739B 0.00
Sage Therapeutics (SAGE) United States $0.654B 0.00
Exscientia (EXAI) United Kingdom $0.617B 0.00
Cassava Sciences (SAVA) United States $0.593B 0.00
Silence Therapeutics (SLN) United Kingdom $0.569B 0.00
ProKidney (PROK) United States $0.564B 0.00
Savara (SVRA) United States $0.557B 0.00
Siga Technologies (SIGA) United States $0.540B 6.90
Lexeo Therapeutics (LXEO) United States $0.528B 0.00
Heron Therapeutics (HRTX) United States $0.527B 0.00
KalVista Pharmaceuticals (KALV) United States $0.497B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.484B 0.00
Altimmune (ALT) United States $0.472B 0.00
Bioventus (BVS) United States $0.455B 17.42
OmniAb (OABI) United States $0.441B 0.00
Esperion Therapeutics (ESPR) United States $0.421B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.412B 0.00
Verve Therapeutics (VERV) United States $0.410B 0.00
Organogenesis (ORGO) United States $0.371B 70.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Xeris Biopharma Holdings (XERS) United States $0.334B 0.00
Tourmaline Bio (TRML) United States $0.330B 0.00
Korro Bio (KRRO) United States $0.314B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.309B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.94
Enanta Pharmaceuticals (ENTA) United States $0.275B 0.00
Black Diamond Therapeutics (BDTX) United States $0.262B 0.00
Foghorn Therapeutics (FHTX) United States $0.245B 0.00
Aquestive Therapeutics (AQST) United States $0.237B 0.00
Nanobiotix S.A (NBTX) France $0.236B 0.00
ESSA Pharma (EPIX) Canada $0.233B 0.00
Nektar Therapeutics (NKTR) United States $0.228B 0.00
Century Therapeutics (IPSC) United States $0.215B 0.00
Akebia Therapeutics (AKBA) United States $0.214B 0.00
Elite Pharmaceuticals (ELTP) United States $0.213B 19.90
Eliem Therapeutics (ELYM) United States $0.212B 0.00
Prelude Therapeutics (PRLD) United States $0.209B 0.00
Profound Medical (PROF) Canada $0.205B 0.00
Zevra Therapeutics (ZVRA) United States $0.205B 0.00
Fractyl Health (GUTS) United States $0.205B 0.00
Avita Medical (RCEL) United States $0.204B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Aldeyra Therapeutics (ALDX) United States $0.197B 0.00
Pyxis Oncology (PYXS) United States $0.195B 0.00
Incannex Healthcare (IXHL) Australia $0.187B 0.00
Acrivon Therapeutics (ACRV) United States $0.179B 0.00
Achieve Life Sciences (ACHV) Canada $0.161B 0.00
Metagenomi (MGX) United States $0.153B 0.00
Context Therapeutics (CNTX) United States $0.150B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.144B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Telomir Pharmaceuticals (TELO) United States $0.142B 0.00
Galectin Therapeutics (GALT) United States $0.140B 0.00
Cardiol Therapeutics (CRDL) Canada $0.139B 0.00
CytoDyn (CYDY) United States $0.138B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.129B 8.64
VAXART, INC (VXRT) United States $0.118B 0.00
Assertio Holdings (ASRT) United States $0.118B 5.39
OptiNose (OPTN) United States $0.118B 0.00
Regulus Therapeutics (RGLS) United States $0.117B 0.00
Journey Medical (DERM) United States $0.113B 0.00
Karyopharm Therapeutics (KPTI) United States $0.108B 0.00
Citius Pharmaceuticals (CTXR) United States $0.105B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
FibroGen (FGEN) United States $0.089B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
AlloVir (ALVR) United States $0.083B 0.00
ProPhase Labs (PRPH) United States $0.080B 0.00
Aclaris Therapeutics (ACRS) United States $0.078B 0.00
Conduit Pharmaceuticals (CDT) United States $0.078B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.076B 1.06
CASI Pharmaceuticals (CASI) China $0.074B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.064B 0.00
Carisma Therapeutics (CARM) United States $0.063B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Mural Oncology (MURA) Ireland $0.053B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
Tempest Therapeutics (TPST) United States $0.049B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Inotiv (NOTV) United States $0.043B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
DURECT (DRRX) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
VYNE Therapeutics (VYNE) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.026B 0.00
BioVie (BIVI) United States $0.025B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Viracta Therapeutics (VIRX) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
JanOne (JAN) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Unicycive Therapeutics (UNCY) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Cosmos Health (COSM) Greece $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
SHINECO (SISI) China $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Talphera (TLPH) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Mannatech (MTEX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.83
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.08